Fig. 8

Biosafety evaluation of CD16/32‑ZIF90@Sp in vivo. A H&E staining of the heart, liver, spleen, lung, and kidney of ApoE−/− mice after different treatments. B Body weight. C Fasting blood glucose level. D Average food intake. E biochemical parameters of ApoE−/− mice after different treatments. n = 6